Mednet Logo

How would you sequence SRS for brain metastases for a patient receiving dual immunotherapies?

Is there an optimal time to give SRS to brain metastases for patients receiving ipilimumab and nivolumab?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Roswell Park Comprehensive Cancer Center
Answered on

To be honest the strategy in this regard at our center has been haphazard at best. I have not seen any adverse effects that could be clearly related to concurrence of combination dual immunotherapy therapy and GK SRS.

My colleague Marc Ernstoff reported results of the Checkmate study which clearly po...

Join for free or sign in to see the full answer